Tower Research Capital (TRC)’s Intellipharmaceuticals International Inc. IPCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-100
| Closed | – | – | 4683 |
|
|
2018
Q4 | $0 | Hold |
100
| – | – | ﹤0.01% | 4708 |
|
|
2018
Q3 | $0 | Buy |
100
+90
| +900% | +$301 | ﹤0.01% | 4553 |
|
|
2018
Q2 | $0 | Hold |
10
| – | – | ﹤0.01% | 4360 |
|
|
2018
Q1 | $0 | Sell |
10
-40
| -80% | -$289 | ﹤0.01% | 4207 |
|
|
2017
Q4 | $0 | Buy |
50
+30
| +150% | +$273 | ﹤0.01% | 4347 |
|
|
2017
Q3 | $0 | Sell |
20
-80
| -80% | -$1.14K | ﹤0.01% | 4360 |
|
|
2017
Q2 | $3K | Buy |
100
+70
| +233% | +$1.47K | ﹤0.01% | 2286 |
|
|
2017
Q1 | $1K | Buy |
30
+10
| +50% | +$258 | ﹤0.01% | 2923 |
|
|
2016
Q4 | $1K | Buy |
+20
| New | +$559 | ﹤0.01% | 3722 |
|
|
2016
Q2 | – | Sell |
-69
| Closed | -$1K | – | 5311 |
|
|
2016
Q1 | $1K | Sell |
69
-52
| -43% | -$1.16K | ﹤0.01% | 3914 |
|
|
2015
Q4 | $2K | Buy |
121
+81
| +203% | +$1.58K | ﹤0.01% | 3899 |
|
|
2015
Q3 | $1K | Sell |
40
-318
| -89% | -$8.36K | ﹤0.01% | 3773 |
|
|
2015
Q2 | $11K | Sell |
358
-1,606
| -82% | -$48.5K | ﹤0.01% | 2647 |
|
|
2015
Q1 | $55K | Buy |
1,964
+194
| +11% | +$4.71K | 0.01% | 1400 |
|
|
2014
Q4 | $40K | Buy |
1,770
+441
| +33% | +$11.9K | ﹤0.01% | 1166 |
|
|
2014
Q3 | $40K | Buy |
1,329
+389
| +41% | +$11.2K | ﹤0.01% | 1739 |
|
|
2014
Q2 | $35K | Buy |
940
+771
| +456% | +$29.7K | ﹤0.01% | 1502 |
|
|
2014
Q1 | $8K | Buy |
169
+88
| +109% | +$3.52K | ﹤0.01% | 2888 |
|
|
2013
Q4 | $3K | Buy |
+81
| New | +$2.17K | ﹤0.01% | 3905 |
|
Tower Research Capital (TRC)'s IPCI Position: Q1 2019 in Review
Tower Research Capital (TRC) sold out of Intellipharmaceuticals International Inc. (IPCI) in Q1 2019, closing a stake of 100 shares.
Tower Research Capital (TRC) first reported a position in IPCI in Q4 2013 and held it in 19 quarters. The position peaked at $55K in Q1 2015. 0 funds tracked by Wall St. Rank hold IPCI as of Q1 2019.
- Tower Research Capital (TRC) reported no remaining Intellipharmaceuticals International Inc. position as of Q1 2019 after selling out during the quarter.
- Tower Research Capital (TRC) sold 100 Intellipharmaceuticals International Inc. shares in Q1 2019.
- Tower Research Capital (TRC) first reported a position in Intellipharmaceuticals International Inc. in Q4 2013 and held it in 19 quarters.
- Tower Research Capital (TRC)'s Intellipharmaceuticals International Inc. position peaked at $55K in Q1 2015.
- 0 funds tracked by Wall St. Rank held Intellipharmaceuticals International Inc. as of Q1 2019.
Based on Tower Research Capital (TRC)'s 13F filing for Q1 2019, filed 14 May 2019.